Cano Health Amends MSP Recovery Stake, Signals Ownership Shift

TL;DR

**Cano Health just updated its MSP Recovery stake, watch for potential stock movement!**

AI Summary

Cano Health, Inc. filed an amended Schedule 13D/A on January 31, 2024, updating its beneficial ownership of MSP Recovery, Inc. Class A Common Stock. This amendment, number 3, indicates a change in the reporting person's holdings or intentions regarding MSP Recovery, Inc. stock, with the triggering event occurring on January 26, 2024. This matters to investors because changes in significant ownership by institutional holders like Cano Health can signal shifts in confidence or strategic intent, potentially influencing MSP Recovery's stock price and future direction.

Why It Matters

This filing indicates a change in Cano Health's ownership or intentions regarding MSP Recovery, Inc., which could impact investor sentiment and the stock's valuation.

Risk Assessment

Risk Level: medium — Changes in significant ownership can introduce uncertainty about a company's future direction or stability, posing a medium risk to current and prospective investors.

Analyst Insight

Investors should monitor subsequent filings from Cano Health for MSP Recovery, Inc. to understand the specific nature of the change in beneficial ownership and its potential implications for MSP Recovery's stock performance.

Key Numbers

• 553745100 — CUSIP Number (identifies MSP Recovery, Inc. Class A Common Stock)
• 0001193125-24-021047 — Accession Number (unique identifier for this specific SEC filing)
• 3 — Amendment Number (indicates this is the third amendment to the original Schedule 13D filing)

Key Players & Entities

• Cano Health, Inc. (company) — the entity filing the SC 13D/A amendment
• MSP Recovery, Inc. (company) — the issuer whose Class A Common Stock is the subject of the filing
• David J. Armstrong, Esq. (person) — General Counsel for Cano Health, authorized to receive notices
• $0.0001 (dollar_amount) — par value per share of MSP Recovery, Inc. Class A Common Stock
• January 26, 2024 (date) — date of the event requiring the filing of this statement

Forward-Looking Statements

• Cano Health may be adjusting its strategic involvement with MSP Recovery, Inc. (Cano Health, Inc.) — medium confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.0001 — suer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d728894dsc13da.htm (SC 13D/A) — 34KB
• 0001193125-24-021047.txt ( ) — 36KB

From the Filing

SC 13D/A 1 d728894dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226-6633 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 26, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: 553745100 1 NAMES OF REPORTING PERSONS Cano Health, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 5,759,630 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 5,759,630 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,759,630 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 40.0%(1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (1) The 5,759,630 shares of Class A common stock of MSP Recovery, Inc. (the Issuer) reported herein represents 4.2% of the Issuers total issued and outstanding voting shares. (See Item 5 of the Schedule 13D.) 2 This Amendment No. 3 ( Amendment No. 3 ) to Schedule 13D relates to the Class A Common Stock, par value $0.0001 per share (the Class A Shares ), of MSP Recovery, Inc., a Delaware corporation (the Issuer ), and amends and supplements the initial statement on Schedule 13D filed by Cano Health, Inc., a Delaware corporation (the Reporting Person ), with the Securities and Exchange Commission ( SEC ) on July 17, 2023, as amended by Amendment No. 1 to the Schedule 13D filed with the SEC on January 12, 2024, as amended by Amendment No. 2 to the Schedule 13D filed with the SEC on January 24, 2024 (as so amended, the Schedule 13D ). Capitalized terms used but not defined in this Amendment No. 3 shall have the same meanings ascribed to them in the Schedule 13D. Item5. Interest in Securities of the Issuer. Items 5(a)-(c) of the Schedule 13D are hereby amended and restated as follows: (a) and (b) The percentage of beneficial ownership of the Class A Shares reported in this Schedule 13D assumes 14,415,930 Class A Shares outstanding as of November 27, 2023, based on information set forth in the Form S-1/A filed by the Issuer on December 8, 2023 (the Form S-1/A ). As of January 30, 2024, the aggregate number and percentage of Class A Shares beneficially owned by the Reporting Person and, for the Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover page of this Schedule 13D and are incorporated herein by reference. As of January 30, 2024, Cano Health, LLC, an indirect subsidiary of the Reporting Person, directly owns the 5,759,630 Class A Shares reported herein representing approximately 40.0% of the Class A Shares outstanding. The 5,759,630 Class A Shares beneficially owned by the Reporting Person represent approximately 4.2% of the Issuers total outstanding voting shares. The Reporting Persons voting power percentage assumes an aggregate of 138,669,106 shares of Issuer voting stock outstanding, consisting of (x) 14,415,930 Class A Shares outstanding as of November 27, 2023, based o

View Full Filing

View this SC 13D/A filing on SEC EDGAR